It has been reported that UPR reduces the NF-κB inhibitor IκBα through several mechanisms [25, 26], which results in NF-κB activation and the regulation of genes involved in inflammation and insulin resistance [24]. This evidence concerns the gene NFKBIA and Insulin resistance.